Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ELUTIA INC.

Get SEC filing alerts via email and in your feed for ELUTIA INC.

ELUT

ELUTIA INC.

About ELUTIA INC.

Elutia Inc. develops regenerative medicine products focused on device protection, women's health, and cardiovascular repair. Its offerings include bioenvelopes with antimicrobial properties and acellular dermal matrices to reduce complications like infection, migration, and fibrosis. The company leverages proprietary tissue engineering, strategic partnerships, and a scalable manufacturing model to serve healthcare providers, aiming to improve surgical outcomes and establish standards in implantable device and tissue reconstruction markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ELUTIA INC.

1
1
ELUTIA INC. Elutia Inc. Reports 5.5% Sales Increase but Wider Net Loss in Q1 2026

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
ELUTIA INC. Elutia Inc. Reports $15.9 Million Net Loss, Completes Divestitures and Focuses on New Product Development

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
ELUTIA INC. Elutia Inc. Reports $3.9 Million Net Loss in Q3 2025 Amid Revenue Decline

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ELUTIA INC. Elutia Inc. Reports Q2 2025 Financial Results with Improved Net Loss and Revenue Stability

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ELUTIA INC. Elutia Inc. Reports $3.9 Million Net Loss in Q1 2025, Revenue Declines 9.9%

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ELUTIA INC. Elutia Inc. Reports $53.9 Million Net Loss for Fiscal Year 2024 Amid Revenue Decline

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
ELUTIA INC. Elutia Inc. Reports Mixed Q3 Results, Net Income Turnaround Amid Ongoing Challenges

Via official filing (AI summary) | over 1 year ago | 0 comments